Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹3,015.3 Cr 1.8% -4.1% -33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,626.0 Cr 1.2% 4.4% -9.7% Stock Analytics
DIVIS LABORATORIES ₹180,669.0 Cr 5.8% 19.2% 16.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 1.4% 1.8% 10.8% Stock Analytics
CIPLA ₹122,103.0 Cr -3.7% -0.2% 1.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,857.4 Cr -7.3% -4% -6.1% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

1.8%

-4.1%

-33.1%

SENSEX

-0.9%

4.6%

5%


You may also like the below Video Courses